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normal corona~ arteries were studied; 14 pts with cardiac syndrome X
(5X, 9 F, age 52 + 7 yeare) and 16 pts with hypertrophic cardiomyopathy
(HCM, 4 F, age 41 &12 years). The clinical status of all pts was unchanged
between the two PET studies. The MBF tracer was 015-water for 5X and
NIS-ammonia for HCM. MBF (mllminfg) was measured at baseline (baa)
and after dipyridamole (dip; 0.56 mgkg in 4 rein) and the CVR computed as
dipMBF/besMBF (absolute units). The coefficient of variation (CV%) of MBF
wea calculated as SD/mean of regional basMBF and dipMBF. Results: Mean
time between studies was 216 days, range 10-662, for 5X and 641 days,
range 36-1765, for HCM. No differences were found between the first and
aemnd study in SX and HCM for measured and derived MBF parameters
(ANOVA, p = NS: table).
SX Ist study SX2ndstudy HCMISt StUdy HCM 2nd study
basMBF 1.16+0.41 1.20 + 0.26 0.6440.27 0.76 + 0.31
dlpMSF 3.11 + 1.08 3.85+ 1.13 1.35 i 0.47 1.40 + 0.69
CVR 2.71 +0.63 3.08+ 0.80 1.68 * 0.54 1.84 + 0.69
bsscv 16+9 16*8 13*9 14*9
dlpCV 27& 13 21 *7 17* 12 16+9
Corrc/usions:The results of the present study show that PET offers repro-
ducible non-invasive measurements of MBF in humans.
m1047145 Effectsof LeftBundleBranchBlockonCardiacPETImaging
P.Zanm,, F.Chierichetti, S. Cargnel, A. Fini, G. Ferlin. Pet Centec
Caste/franco Veneto, Italy
To evaluate the effects of left bundle branch block (LBBB) on perfusion and
metabolic cardiac PET imaging, 20 patients (16 M,2 F,aged 51-74 yra, mean
64) affected byperrnanent, complete LBBBwereenrolled and submitted to: 1)
glucose load F18-fluorodeoxiglucose PET(FDG-PET); 2) rest N13-ammonia
PET (NH3-PET); 3) coronary angiography; 4) echocerdiography. Eleven pts
presented a history of a previous myocerdial infarction, anterior in focalization
in 4 and infero-posterior in the other 7 at the echocardiography.The other 9
pts presented a left ventricular dilatation, without signs of previous necrosis.
At the mronary angiogrephy 12 pts presented a significant stenosis of LAD,
8 of these with involvement of other coronaries, while 2 pts presented only
stenoses in RCA and LCX and in the other 6 pts no significant coronaty
stenosis was found. At the FDG-PET all the LBBB pts presented a severe
uptake defect (< 50% of the maximum) in the septum, extending to nearby
regions of the anterior and inferior left ventricular wall, overall involving from
40 to 60% of the ventricle wall. In the corresponding area the perfusion,
evaluated by NH3-PET, was presewed. At the echocardiography tha wall
motion segmental analysis revealed no significant correlation between the
dysfunctional area and the site of the FDG uptake defect.
In mnclusion our study could suggest that: 1) in Lr3BBa change in the
metabolic activity of the septum without damage in perfusion was present; 2)
this was evident also in the ptawithout LAD stenosis; 3) in LBBBptsaviability
study using FDG-PET may overestimate the extension of the necrosis, to
avoid this misinterpretation it appears advisable to perform a perfusion PET
study using N13-NH3 as well.
1047-146 DeieyedFDGimagingImproves
Myocardial/BloodPoolContrast
G. Srinivaaan, S.L. Bacharach, A.N. Kitsiou, K.A. Nour, C.M. Davis,
V. Dilsizian. National Institutes of Hea/th, Bethesda, MD, USA
In some pte with CAD, imaging of the myocerdium with F-18 deoxygiucose
(FDG) at 30-80 min post injection by PET produces images with Iowcontrast
between myocardium and blood pool. We hypothesized that imaging at
a later time might improve the quality of FDG images both by increasing
myocerdial uptake and clearance of FDG from the blood. We tested this
hypothesis in 7 pts with CAD: 6 men, 1 woman, age 66 + 11; 3 diabetics.
PET images were acquired both at 30-60 min post injection of 57-10 mCi
of FDG (1 hr after glucose load) and at 135-165 min. For each pt, the
antire LV was divided into 41 approximately equal segments. Both absolute
(nCi/ccimCi) and normalized (to peak thallium activity on stress) FDG uptake
were analyzed. All data were decay correctedto time of injection. Normalized
early and late FDG values were highly correlated (slope = 1.26, intercept =
-0.25, r = 0.92, SEE= 0.05), implying eariy and late images provide similar
clinical information. Of215 segments, 206 (97%) were cancoru’antforviability
between early and late imaging. Myocardial FDG uptake increased on late
imaging (77 + 27 early vs 116 + 57 late, p < 0.05). In all pta, late imaging
wa8 associated with decreased blood pool activity (34+ 6.6 early vs 18 + 7.1
late, p < 0.01), resulting in improved late myocardium/blood pool contrast
ratio (2.3 early va 7.1 late, p < 0.01). This improvement in myocerdial
contrast was similar for diabetics (from 2.1 to 6.5) and non diabetics (from
2.5 to 7.6), and was consistent with marked visual improvement, These data
suggest that despite a slight decrease in myocerdial counts due to decay,
the increased myocardial FDG uptake combined with decreased blood pool
activity improves late image quality. The good early-late FDG correlation
suggests that the improvement does not alter the FDG distribution in a
clinically significant way, but this needs to be verified in a larger number of
pts.
PY] Predi.tivaVaiueof FDGimaginginPatientaVifith
Chronic iachaemic Left Ventricular Dysfunction
Enrolled in a Prospective European Muiticentre
Viability Study
F. Fath-Ordoubadi. EEC CorrcertedAction on Positron Emission
Tornograpfry(PET) kwestigation of Ce//u/arr?egerteration and
Degeneration, London, UK, Louvain, B, Lyon, France, Groningen, NL,
Li&a, B, Turku,SE Copenhagen, Denmark, Germany
Aim of this study was to ascertain the value of quantitative PET with 1SF-
fluorodeoxyglucose (FDG) to identify hibernating myocardium. A total of 502
patients (pts) with at least one dysfunctional (D) segment (S) subtended by a
stenotic coronary artery amenable to revascularization (R) were enrolled over
2 years. Left ventricular (LV) function was assessed before and 4-6 months
after R by radionuciide ventriculography or echocarciiogrephy. To maximize
myocardial FDG uptake and overcome insulin resistance, all studies were
performed during euglycemic hyperinsulinemic clamp (EHC). A total of 254
pts have undergone R, by angioplasty (14%) or bypass. Complete follow up
data on 121 pts (age 59 + 9) who had R are available: LV ejection fraction
(EF) was 37 + 13% before and 40 + 15% after R (p < 0.01); the ragional
wall motion score (1 = normal; 2 = hypokinetic; 3 = akinetic; 4 = dyskinatic)
was 2.0 + 0.6 before and 1.7 + 0.6 after R (p < 0.001). A total of 326 S
were normal (N) and 382 D. After R, 204 (53%) D-S improved (IMP), 149
(39%) were unchanged (UNC) and 29 (6%) worsened. The Metabolic Rate
of Glucose (MRG; &mol/min/g; lump constant = 1) was 0.42 + 0.18. in N-S,
0.36 + 0.17 in IMP-S (p <0.01 vs N) and 0.31 + 0.17 in UNC-S (p <0.01
vs N and IMP). /n conclusion, these interim results indicate that FDG-PET
during EHC can provide the quantitative assessment of myocardial viability
in the absence of perfusion measurement.
_ MyoCardiS,BIOodFioWchan~eaDuringLoW
Dose Dobutamine Infusion: Relation to F-18
Daoxygiucose Uptake
A.N. Kitsiou, S.L. Bacharach, C.M. Davis, G. Srinivasan, K.A. Nour,
A.A. Quyyumi, V. Dilsizian. National krstitutes oflfeakh, Bathesda, MD, USA
In asynergic myocardial regions rendered dysfunctional by chronic hypop-
erfusion, F-18 deoxyglucose (FDG) is useful in differentiating viable from
scarred myocardium. In this study, we determined whether regional myocer-
dial blood flow (MBF) res~nse during low dose dobutamine (LDD) infusion
also differentiates hypoperfused but viable from scarred myocardium when
compared to FDG uptake. To this end, 11 pts (mean age 65 + 9 years)
with chronic CAD and LV dysfunction (mean LVEF = 32 + 6%) underwent
positron emission tomography (PET) with N-13 ammonia (NHJ and FOG.
Absolute MBF was mmputed at rest and during LDD (5 #g/kg/rein) infusion,
using a two compartment NH3 model. Four to five NH3 and FDG PET slicea
(8 regions per slice) were matched and analyzed for each patient. Rest and
LDD N-13 ammonia data were then analyzed according to the magnitude of
FDG uptake.
FOG (% uptake) N-13 Ammonia (ml/min/g)
Reat Low-doaeDobutsmirw
Normal (> so%) 0.64 * 0.1s 0.96 + 0.32
At rest, MBFwas similar in regions with moderately and severely reduced
FDG uptake. During LDD infusion, although mean MBF increased in all three
categories, the extent of MBF increase was significantly greater in regions
with moderately than in regions with severely reduced FDG uptake (0.35 +
0.26 vs 0.20 + 0.30 ml/min/g, p c 0.05). Furthermore, 85% of regions with
moderately reduced FDG uptake showed mismatch pattern (FDG: MBF >
110).These data suggest that an assessment of MBF response during LDD
infusion may differentiate hypoperfused but viable from nonviable myocardial
regions.
